As companies around the world welcome back employees and customers, the lingering feeling of safety can be addressed with proper use of a screening system.
Bio-Stream Diagnostics Inc. builds and supplies uncomplicated platforms for the molecular-level detection of pathogens in the workplace. We are starting with a purpose-built, employee-screening platform for the SARS-CoV-2 virus.
Our team of experts is developing the next generation of pathogen screening technology and software. It is specifically designed for proactive, regular and ongoing testing of large numbers of people.
Bio-Stream: At a Glance
About Us
Bio-Stream Diagnostics Inc. is a privately-owned corporation headquartered in Edmonton, Alberta, Canada. The company was started in 2020 to develop and commercialize a best-of-class pathogen detection platform.
The SARS-CoV-2 virus has primed the global market for human pathogen detection in a historically unprecedented way. Post-pandemic, the appetite for affordable and accurate point-of-care pathogen testing will remain. In order to minimize the risk of pathogen-related shutdowns and disruption, routine screening of employees, contractors, and customers will need to become part of corporate health and safety culture.
CEOs need to satisfy their employees, underwriters, shareholders, customers, and suppliers by ensuring they have done everything possible to mitigate the business and safety risks posed by viruses and other pathogens.
Our tests are being developed specifically for corporate enterprises and other organizations that need to routinely screen large numbers of people for the purposes of maintaining workplace health and safety.
Thank you to our collaborators…
